SCHEMBL4517818

SCHEMBL4517818

CC(C)c1csc2c1c(O)c(C(=O)N(C)c1ccccc1)c(=O)n2C

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.54
MEN1 O00255 2/20 0.54
PGR P06401 1/20 0.54
SRC P12931 1/20 0.41
HDAC4 P56524 1/20 0.41
LIPE Q05469 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
GNRHR P30968 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33
P2RX7 Q99572 1/20 0.33
POLB P06746 1/20 0.33
KDM4E B2RXH2 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
ERCC5 P28715 1/20 0.32
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4508085 0.89 KMT2A (0.51) KMT2AMEN1PGRSRCHDAC4
SCHEMBL4513061 0.86 MEN1 (0.39) KMT2AMEN1PGRTP53MAPT
SCHEMBL4509473 0.85 KMT2A (0.57) KMT2AMEN1PGRSRCHDAC4
SCHEMBL4506552 0.84 KMT2A (0.56) KMT2AMEN1PGRSRCHDAC4
SCHEMBL4496687 0.84 KMT2A (0.56) KMT2AMEN1PGRSRCHDAC4
SCHEMBL4510344 0.84 KMT2A (0.56) KMT2AMEN1PGRSRCHDAC4
SCHEMBL5236265 0.84 KMT2A (0.56) KMT2AMEN1PGRSRCHDAC4
SCHEMBL4507747 0.84 KMT2A (0.56) KMT2AMEN1PGRSRCHDAC4
SCHEMBL4512701 0.84 MEN1 (0.51) KMT2AMEN1PGRSRCHDAC4
SCHEMBL4517618 0.83 KMT2A (0.55) KMT2AMEN1PGRSRCHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553849-B2 Compounds ACTIVE BIOTECH AB (SE) 2009-06-30 US claimed
EP-1776369-B1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE ACTIVE BIOTECH AB (SE) 2007-10-10 EP claimed
US-20060004038-A1 Novel compounds ACTIVE BIOTECH AB (SE) 2006-01-05 US claimed
US-7553849-B2 Compounds ACTIVE BIOTECH AB (SE) 2009-06-30 US disclosed
EP-1776369-B1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE ACTIVE BIOTECH AB (SE) 2007-10-10 EP disclosed
US-20060004038-A1 Novel compounds ACTIVE BIOTECH AB (SE) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004038-A1 Novel compounds REL, CLIC4, C5 KMT2A 4071/4885MEN1 509/4885PGR 438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.